 SAN DIEGO, July 8, 2021 PRNewswire -- Neurocrine Biosciences, Inc. Nasdaq: NBIX today announced that Kyle Gano, Chief Business Development and Strategy Officer, will participate in a neuropsychology-focused panel discussion at the William Blair Biotech Focus Conference at 12:00 p.m. Eastern Time on Thursday July 15, 2021. 